Anti migraine drugs could be a game changer

Headache, a word which is enough to scare even the bravest person is a daily problem for many people all over the world. The problem of migraine has affected a lot of people and a many research and studies have been carried out in the past to find a way to prevent it from happening. In this regard, according to a new study that was put forward at the American Headache Society, it was stated that some new drugs have been created which can prevent migraines. This news comes as a relief to many and is likely to cheer up around 30 million people in America who suffer from migraine.

The conference where the study results were put forward took place in Washington, between the 18th and 21st of June. The new class of drugs was unveiled there as they showed promise towards both preventing and curing migraines. Headaches are always painful, be it the light ones or the intense ones. They can greatly affect your work efficiency and render you helpless. A drug amidst all this would be a very good thing to have for a migraine patient. The effectiveness of this drug can be attributed to the fact that it is able to target a biochemical named calcitonin gene-related peptide (CGRP), which is considered to be the root cause of migraines.

Image: CC BY-ND 2.0

As of now, only four companies are said to have been involved in trials. These four manufacturers are:Teva Pharmaceuticals, Eli Lilly and Company, Amgen, Alder Pharmaceuticals. The tests have found that about 50 percent of people who tried the treatment got positive results from it. The other thing that the manufacturers will have to look into is the adverse or side effects of these drugs. However, so far there haven’t been any side effects recorded. These drugs can be taken in the form of injection right now which could be a downside. The injection frequency is once per month.

The companies are trying hard to get the drugs into market as soon as possible but it will not happen anytime soon as they are still in experimental phase. One thing is for sure that if the drugs make it through the trial phase they will be a huge relief to the migraine patients globally.